1. Home
  2. MRBK vs RNAC Comparison

MRBK vs RNAC Comparison

Compare MRBK & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

N/A

Current Price

$19.69

Market Cap

236.1M

Sector

Finance

ML Signal

N/A

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.95

Market Cap

238.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
RNAC
Founded
2004
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.1M
238.9M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
MRBK
RNAC
Price
$19.69
$8.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$20.75
$34.00
AVG Volume (30 Days)
71.1K
101.7K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.05%
N/A
EPS Growth
30.34
N/A
EPS
0.64
N/A
Revenue
$6,316,000.00
$2,797,000.00
Revenue This Year
$25.40
N/A
Revenue Next Year
$8.15
N/A
P/E Ratio
$30.95
N/A
Revenue Growth
10.13
N/A
52 Week Low
$13.81
$5.60
52 Week High
$21.59
$11.00

Technical Indicators

Market Signals
Indicator
MRBK
RNAC
Relative Strength Index (RSI) 50.38 48.36
Support Level $19.28 $8.80
Resistance Level $20.69 $9.27
Average True Range (ATR) 0.58 0.69
MACD 0.02 -0.12
Stochastic Oscillator 36.39 17.14

Price Performance

Historical Comparison
MRBK
RNAC

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: